Apap Tab



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 86.4%
Depression 4.5%
Pain 4.5%
Suicide Attempt 4.5%
Agitation 20.0%
Drug Administration Error 20.0%
Hypothermia 10.0%
Metabolic Acidosis 10.0%
Paraesthesia 10.0%
Plasminogen Activator Inhibitor 10.0%
Tachycardia 10.0%
Vomiting 10.0%
Secondary
Product Used For Unknown Indication 26.2%
Drug Use For Unknown Indication 20.5%
Cancer Pain 10.3%
Multiple Drug Overdose 8.2%
Pain 7.7%
Oral Contraception 6.2%
Hypertension 4.1%
Menstruation Irregular 4.1%
Ovarian Cyst 4.1%
Self Injurious Behaviour 2.1%
Intentional Drug Misuse 1.5%
Intentional Overdose 1.5%
Overdose 1.5%
Asthma 0.5%
Depression 0.5%
Post-traumatic Stress Disorder 0.5%
Stent Placement 0.5%
Suicide Attempt 15.0%
Prostate Cancer 10.0%
Intentional Self-injury 7.5%
Somnolence 7.5%
Vomiting 7.5%
Agitation 5.0%
Disease Progression 5.0%
Drug Administration Error 5.0%
Nausea 5.0%
Neoplasm Malignant 5.0%
Respiratory Arrest 5.0%
Cholelithiasis 2.5%
Cholesterosis 2.5%
Hepatocellular Damage 2.5%
Hepatomegaly 2.5%
Hypothermia 2.5%
Joint Instability 2.5%
Multiple Drug Overdose 2.5%
Multiple Drug Overdose Intentional 2.5%
Pain In Extremity 2.5%
Concomitant
Pain 14.6%
Product Used For Unknown Indication 12.1%
Drug Use For Unknown Indication 11.8%
Premedication 9.8%
Atrial Fibrillation 7.0%
Hypertension 5.7%
Depression 4.7%
Multiple Sclerosis 3.4%
Multiple Myeloma 3.1%
Neoplasm Malignant 2.9%
Arthritis 2.8%
Back Pain 2.8%
Contraception 2.6%
Gastrooesophageal Reflux Disease 2.6%
Nasopharyngitis 2.6%
Bipolar Disorder 2.5%
Constipation 2.3%
Osteoarthritis 2.3%
Crohn's Disease 2.1%
Deep Vein Thrombosis 2.1%
Vomiting 20.4%
Unresponsive To Stimuli 7.5%
Rash 6.1%
Myocardial Infarction 5.4%
Ventricular Septal Defect 5.4%
Weight Decreased 5.4%
Respiratory Failure 4.8%
Syncope 4.8%
Pulmonary Embolism 4.1%
Thrombocytopenia 4.1%
White Blood Cell Count Decreased 4.1%
Death 3.4%
Mental Status Changes 3.4%
Platelet Count Decreased 3.4%
Pneumonia 3.4%
Pyrexia 3.4%
Anxiety 2.7%
Cardiac Failure Congestive 2.7%
Gastrointestinal Haemorrhage 2.7%
Heparin-induced Thrombocytopenia 2.7%